Edward K. Duran

Edward K. Duran

Auto-generated profile, based on publicly available information

Edward K. Duran

Brigham and Women’s Hospital, Harvard Medical School

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2021 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Open access
PDF file
AAAaron W. Aday
Aaron W. Aday
EDEdward K. Duran
Edward K. Duran
MDMartin Van Denburgh
Martin Van Denburgh
EKEun-Jung Kim
Eun-Jung Kim
WCWilliam G. Christen
William G. Christen
APAruna D. Pradhan
Aruna D. Pradhan
Objective: Case-control studies have identified plasma homocysteine as a risk marker for venous thromboembolism (VTE). Prospective data, particularly among women, are sparse. We examined whether plasma homocysteine associates with incident VTE in 2 large prospective cohorts of women. Approach and Results: In the WHS (Women’s Health Study), a prospective cohort study of 27 555 women ≥45 years old and free of cardiovascular disease and VTE, we assessed baseline homocysteine concentration along with other thrombotic biomarkers for association with future VTE (n=743), pulmonary embolism (n=363), and deep vein thrombosis (n=545). We used a second cohort of 2672 women (n=102 VTE events) in the WAFACS (Women’s Antioxidant and Folic Acid Cardiovascular Study) to corroborate our findings. In age-adjusted analyses, elevated homocysteine, hsCRP (high-sensitivity C-reactive protein), fibrinogen, and sICAM-1 (soluble intercellular adhesion molecule-1) were associated with incident VTE ( P for extreme quartile comparisons and P -trend <0.05). In multivariable models adjusting for body mass index and other traditional VTE risk factors, only the association for homocysteine persisted (HR Q4 , 1.31 [95% CI, 1.06–1.63]). Elevated homocysteine levels were associated with unprovoked pulmonary embolism (HR Q4 , 2.13 [95% CI, 1.30–3.51]) and deep vein thrombosis (HR Q4 , 1.59 [95% CI, 1.05–2.40]) but not provoked events. In WAFACS, elevated homocysteine levels were also associated with VTE events ( P -trend 0.023). Conclusions: Higher plasma homocysteine levels associate with VTE events in 2 cohorts of middle-aged and older women. Among VTE subtypes, homocysteine was associated with unprovoked, but not provoked, events. These data suggest a plausible biological role for homocysteine in the development of VTE. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00000479, NCT00000541.

5 September 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
EDEdward K. Duran
Edward K. Duran
NCNancy R. Cook
Nancy R. Cook
AAAaron W. Aday
Aaron W. Aday
JBJulie E. Buring
Julie E. Buring
PRPaul M Ridker
Paul M Ridker
APAruna D. Pradhan
Aruna D. Pradhan
Background: Traditional cardiovascular risk assessment entails investigator‐defined exposure levels and individual risk markers in multivariable analysis. We sought to determine whether an alternative unbiased learning analysis might provide further insights into vascular risk. Methods: We conducted an unsupervised learning (k‐means cluster) analysis in the Women's Health Study (N=26 443) using baseline levels of triglycerides, high‐sensitivity C‐reactive protein, and low‐density lipoprotein cholesterol to form novel exposures. We then evaluated cluster‐based risk of incident coronary, cerebrovascular, and limb events using the Kaplan–Meier method and multivariable Cox models, followed by comparison with established clinical biomarker thresholds. Finally, we illustrated clinical applicability to a nonvascular outcome (type 2 diabetes). Results: Four clusters emerged and were named according to aggregate biomarker profiles: Cluster 1 (“healthy,” n=12 101), cluster 2 (“hypercholesterolemic,” n=7424), cluster 3 (“inflammatory,” n=5056), and cluster 4 (“triglyceride‐rich,” n=1862). Triglyceride‐rich cluster identity conferred the highest risk of future cardiovascular events (adjusted hazard ratio [HR adj ], 2.24 [95% CI, 1.93–2.60]) compared with those in the healthy cluster (reference group). Risk was intermediate in the hypercholesterolemic (predominantly elevated low‐density lipoprotein cholesterol) and inflammatory (predominantly elevated high‐sensitivity C‐reactive protein) clusters (HR adj , 1.44 [95% CI, 1.28–1.61]; and 1.54 [95% CI, 1.35–1.75], respectively). Clustering yielded stronger total cardiovascular disease risk associations than traditionally defined mixed dyslipidemia with modest improvement in reclassification statistics. Cluster identities also predicted incident type 2 diabetes, with the greatest risk among the triglyceride‐rich cluster (HR adj , 3.78 [95% CI, 3.29–4.35]). Conclusions: Unsupervised learning analyses demonstrated associations that may be useful when refining cardiovascular risk and may inform atherosclerosis development in healthy individuals better than traditional classification methods. Registration: URL: https://clinicaltrials.gov ; Unique identifier: NCT00000479.